TORONTO — Some of the most active companies traded Friday on the Toronto Stock Exchange:
Toronto Stock Exchange (18,930.48, down 73.58 points.)
Athabasca Oil Corp. (TSX:ATH). Energy. Down 26 cents, or 8.8 per cent, to $2.70 on 39.2 million shares.
Suncor Energy Inc. (TSX:SU). Energy. Down $2.94, or 6.2 per cent, to $44.72 on 27.2 million shares.
Cenovus Energy Inc. (TSX:CVE). Energy. Down $1.14, or 4.4 per cent, to $24.81 on 19.1 million shares.
Argonaut Gold Inc. (TSX:AR). Materials. Down 11 cents, or 10.9 per cent, to 90 cents on 18.7 million shares.
Crescent Point Energy Corp. (TSX:CPG). Energy. Down 81 cents, or 7.3 per cent, to $10.25 on 15.8 million shares.
Canadian Natural Resources (TSX:CNQ). Energy. Down $3.64, or 5.1 per cent, to $68.35 on 14.3 million shares.
Companies in the news:
Bausch Health Companies Inc. (TSX:BHC). Up 18 cents or 1.9 per cent to $9.58. Bausch Health Companies Inc. is suspending plans for an initial public offering of its Solta Medical business due to what it says are challenging market conditions and other factors. The company says it believes the interests of the company’s stakeholders are best served in the near-term by focusing on Solta’s revenue, profits and cash flow. Stock markets have been under pressure in recent weeks, trading well off their highs reached earlier this year. Solta is a skin care company. Bausch Health says it will remain as part of the company and continue to contribute to the deleveraging of its balance sheet, but that it will revisit alternative paths for Solta in the future. The company completed an initial public offering of its eye health business Bausch + Lomb earlier this year.
Hexo Corp. (TSX:HEXO). Down one cent or 3.8 per cent to 25.5 cents. Cannabis company Hexo Corp. says Zenabis Global Inc., a wholly owned subsidiary, has filed for protection under the Companies’ Creditors Arrangement Act. The company says Zenabis made the filing in Quebec Superior Court to restructure its business and financial affairs. Hexo says the petition is limited to the Zenabis Group. Neither Hexo nor any of its subsidiaries, other than the members of the Zenabis Group, are petitioners or parties to the proceedings, the company says. Hexo says Ernst and Young Inc. has been appointed as the monitor to oversee the CCAA proceedings. Hexo bought Zenabis last year for $235 million.
This report by The Canadian Press was first published June 17, 2022.